author-photo

Kiyonobu Okada

Toray Industries

5

Papers

31

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Effects of sustained‐release beraprost in patients with primary glomerular disease or nephrosclerosis: CASSIOPEIR study results

2019 Therapeutic Apheresis and Dialysis
Show All
- Source
- Cite
- Save
Citations (3)
The Pharmacokinetics of Beraprost Sodium Following Single Oral Administration to Subjects With Impaired Kidney Function

2017 The Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (7)
Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial

2015 BMC Nephrology
Show All
- Source
- Cite
- Save
Citations (16)
A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design

2014 BMC Nephrology
Show All
- Source
- Cite
- Save
Citations (5)